These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality. Arora S; Jenum PA; Aukrust P; Rollag H; Andreassen AK; Simonsen S; Gude E; Fiane AE; Geiran O; Gullestad L J Am Coll Cardiol; 2007 Nov; 50(20):1967-72. PubMed ID: 17996562 [TBL] [Abstract][Full Text] [Related]
4. Negative pretransplant serostatus for Toxoplasma gondii is associated with impaired survival after heart transplantation. Doesch AO; Ammon K; Konstandin M; Celik S; Kristen A; Frankenstein L; Müller S; Sack FU; Katus HA; Dengler TJ Transpl Int; 2010 Apr; 23(4):382-9. PubMed ID: 19912587 [TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii Serology and Outcomes After Heart Transplantation: Contention in the Literature. Chehrazi-Raffle A; Luu M; Yu Z; Liou F; Kittleson M; Hamilton M; Kobashigawa J Transplant Proc; 2015; 47(6):1949-53. PubMed ID: 26293079 [TBL] [Abstract][Full Text] [Related]
6. Toxoplasma gondii serostatus is not associated with impaired long-term survival after heart transplantation. van Hellemond JJ; van Domburg RT; Caliskan K; Birim O; Balk AH Transplantation; 2013 Dec; 96(12):1052-8. PubMed ID: 24092380 [TBL] [Abstract][Full Text] [Related]
7. Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry. Wever-Pinzon O; Edwards LB; Taylor DO; Kfoury AG; Drakos SG; Selzman CH; Fang JC; Lund LH; Stehlik J J Heart Lung Transplant; 2017 Apr; 36(4):407-417. PubMed ID: 27686602 [TBL] [Abstract][Full Text] [Related]
8. Donor/recipient sex mismatch and survival after heart transplantation: only an issue in male recipients? An analysis of the Spanish Heart Transplantation Registry. Martinez-Selles M; Almenar L; Paniagua-Martin MJ; Segovia J; Delgado JF; Arizón JM; Ayesta A; Lage E; Brossa V; Manito N; Pérez-Villa F; Diaz-Molina B; Rábago G; Blasco-Peiró T; De La Fuente Galán L; Pascual-Figal D; Gonzalez-Vilchez F; Transpl Int; 2015 Mar; 28(3):305-13. PubMed ID: 25399778 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients. Gasink LB; Blumberg EA; Localio AR; Desai SS; Israni AK; Lautenbach E JAMA; 2006 Oct; 296(15):1843-50. PubMed ID: 17047214 [TBL] [Abstract][Full Text] [Related]
10. Impact of donor variables on heart transplantation outcomes in mechanically bridged versus standard recipients†. Urban M; Booth K; Jungschleger J; Netuka I; Schueler S; MacGowan G Interact Cardiovasc Thorac Surg; 2019 Mar; 28(3):455-464. PubMed ID: 30169835 [TBL] [Abstract][Full Text] [Related]
11. Pre-Transplant Seroprevalence, Associated Factors, and Post-Transplant Incidence of Toxoplasma gondii Infection Among Heart Transplant Recipients in Japan. Kanno Y; Okamoto K; Shinohara T; Kinoshita O; Hatano M; Ikeda M; Harada S; Okugawa S; Moriya K; Ono M; Tsutsumi T Transplant Proc; 2024; 56(1):148-152. PubMed ID: 38177043 [TBL] [Abstract][Full Text] [Related]
12. Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry. Bonser RS; Taylor R; Collett D; Thomas HL; Dark JH; Neuberger J; Lancet; 2012 Aug; 380(9843):747-55. PubMed ID: 22647758 [TBL] [Abstract][Full Text] [Related]
13. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999. Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G Clin Transpl; 2003; ():89-100. PubMed ID: 15387100 [TBL] [Abstract][Full Text] [Related]
14. Outcome of Toxoplasma gondii mismatches in heart transplant recipients over a period of 8 years. Orr KE; Gould FK; Short G; Dark JH; Hilton CJ; Corris PA; Freeman R J Infect; 1994 Nov; 29(3):249-53. PubMed ID: 7884217 [TBL] [Abstract][Full Text] [Related]
15. Donor-recipient size matching and mortality in heart transplantation: Influence of body mass index and gender. Bergenfeldt H; Stehlik J; Höglund P; Andersson B; Nilsson J J Heart Lung Transplant; 2017 Sep; 36(9):940-947. PubMed ID: 28259595 [TBL] [Abstract][Full Text] [Related]
16. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation. Keck BM; Bennett LE; Fiol BS; Dally OP; Novick RJ; Hosenpud JD Clin Transpl; 1996; ():31-45. PubMed ID: 9286557 [TBL] [Abstract][Full Text] [Related]
17. Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents. Whitson BA; Kilic A; Lehman A; Wehr A; Hasan A; Haas G; Hayes D; Sai-Sudhakar CB; Higgins RS Clin Transplant; 2015 Jan; 29(1):9-17. PubMed ID: 25284138 [TBL] [Abstract][Full Text] [Related]
18. Low seroprevalence and low incidence of infection with Toxoplasma gondii (Nicolle et Manceaux, 1908) in pediatric hematopoietic cell transplantation donors and recipients: Polish nationwide study. Czyzewski K; Fraczkiewicz J; Salamonowicz M; Pieczonka A; Zajac-Spychala O; Zaucha-Prazmo A; Gozdzik J; Styczynski J Folia Parasitol (Praha); 2019 Nov; 66():. PubMed ID: 31823860 [TBL] [Abstract][Full Text] [Related]